322 related articles for article (PubMed ID: 21596285)
21. Caspofungin.
Parakh A; Dubey AP; Samanta D
Indian Pediatr; 2008 Nov; 45(11):905-10. PubMed ID: 19029563
[TBL] [Abstract][Full Text] [Related]
22. [Micafungin in pediatric and adolescent patients].
Madero-López L
Rev Iberoam Micol; 2009 Mar; 26(1):62-4. PubMed ID: 19463279
[TBL] [Abstract][Full Text] [Related]
23. Emerging echinocandins for treatment of invasive fungal infections.
Turner MS; Drew RH; Perfect JR
Expert Opin Emerg Drugs; 2006 May; 11(2):231-50. PubMed ID: 16634699
[TBL] [Abstract][Full Text] [Related]
24. Caspofungin for the treatment of pediatric fungal infections.
Fisher BT; Zaoutis T
Pediatr Infect Dis J; 2008 Dec; 27(12):1099-102. PubMed ID: 19057369
[No Abstract] [Full Text] [Related]
25. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
Agarwal MB; Rathi SA; Ratho N; Subramanian R
J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
[TBL] [Abstract][Full Text] [Related]
26. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
Cross SA; Scott LJ
Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
[TBL] [Abstract][Full Text] [Related]
27. In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.
Lockhart SR; Zimbeck AJ; Baddley JW; Marr KA; Andes DR; Walsh TJ; Kauffman CA; Kontoyiannis DP; Ito JI; Pappas PG; Chiller T
Antimicrob Agents Chemother; 2011 Aug; 55(8):3944-6. PubMed ID: 21670187
[TBL] [Abstract][Full Text] [Related]
28. Micafungin: pharmacology, experimental therapeutics and clinical applications.
Groll AH; Stergiopoulou T; Roilides E; Walsh TJ
Expert Opin Investig Drugs; 2005 Apr; 14(4):489-509. PubMed ID: 15882123
[TBL] [Abstract][Full Text] [Related]
29. Role of micafungin in the antifungal armamentarium.
Ikeda F; Tanaka S; Ohki H; Matsumoto S; Maki K; Katashima M; Barrett D; Aoki Y
Curr Med Chem; 2007; 14(11):1263-75. PubMed ID: 17504145
[TBL] [Abstract][Full Text] [Related]
30. Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside.
Aruanno M; Glampedakis E; Lamoth F
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138565
[TBL] [Abstract][Full Text] [Related]
31. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
Salavert-Lletí M; Zaragoza-Crespo R
Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
[TBL] [Abstract][Full Text] [Related]
32. [Activity of micafungin against Candida biofilms].
Quindós G; Villar-Vidal M; Eraso E
Rev Iberoam Micol; 2009 Mar; 26(1):49-55. PubMed ID: 19463277
[TBL] [Abstract][Full Text] [Related]
33. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
[TBL] [Abstract][Full Text] [Related]
34. Echinocandins: addressing outstanding questions surrounding treatment of invasive fungal infections.
Holt SL; Drew RH
Am J Health Syst Pharm; 2011 Jul; 68(13):1207-20. PubMed ID: 21690427
[TBL] [Abstract][Full Text] [Related]
35. New antifungal agents.
Gupta AK; Tomas E
Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
[TBL] [Abstract][Full Text] [Related]
36. Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature.
Wilke M
Eur J Med Res; 2011 Apr; 16(4):180-6. PubMed ID: 21486732
[TBL] [Abstract][Full Text] [Related]
37. Update on echinocandin antifungals.
Kauffman CA; Carver PL
Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.
Maximova N; Schillani G; Simeone R; Maestro A; Zanon D
Adv Ther; 2017 May; 34(5):1184-1199. PubMed ID: 28429246
[TBL] [Abstract][Full Text] [Related]
39. Clinical indications for newer antifungal agents.
Naeger-Murphy N; Pile JC
J Hosp Med; 2009 Feb; 4(2):102-11. PubMed ID: 19219926
[TBL] [Abstract][Full Text] [Related]
40. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
Groll AH; Walsh TJ
Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
